REGENXBIO Inc. (RGNX) is a publicly traded Healthcare sector company. As of May 20, 2026, RGNX trades at $5.99 with a market cap of $292.09M and a P/E ratio of -1.04. RGNX moved +5.12% today. Year to date, RGNX is -55.45%; over the trailing twelve months it is -40.30%. Its 52-week range spans $5.04 to $16.19. Analyst consensus is strong buy with an average price target of $21.69. Rallies surfaces RGNX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who is trading RGNX stock inside the company?
Recent RGNX insider activity includes PAKOLA STEVE sold 15.31K, PAKOLA STEVE sold 5.12K, Simpson Curran sold 20.81K, Simpson Curran sold 7.62K, and Simpson Curran sold 7.73K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
RGNX Key Metrics
Key financial metrics for RGNX
Metric
Value
Price
$5.99
Market Cap
$292.09M
P/E Ratio
-1.04
EPS
$-5.60
Dividend Yield
0.00%
52-Week High
$16.19
52-Week Low
$5.04
Volume
2.06M
Avg Volume
0
Revenue (TTM)
$87.82M
Net Income
$-290.01M
Gross Margin
0.00%
Recent RGNX Insider Trades
PAKOLA STEVE sold 15.31K (~$168.71K) on May 11, 2026.
PAKOLA STEVE sold 5.12K (~$53.03K) on Mar 10, 2026.
Simpson Curran sold 20.81K (~$262.63K) on Oct 9, 2025.
Simpson Curran sold 7.62K (~$76.47K) on Sep 29, 2025.
Simpson Curran sold 7.73K (~$77.49K) on Sep 10, 2025.
Recent RGNX insider activity includes PAKOLA STEVE sold 15.31K, PAKOLA STEVE sold 5.12K, Simpson Curran sold 20.81K, Simpson Curran sold 7.62K, and Simpson Curran sold 7.73K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for RGNX?
Yes. Rallies tracks RGNX insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is RGNX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for RGNX. It does not provide personalized investment advice.
